Lilly’s catch-up act in psoriasis is working, but now it has to catch up in cancer
admin 25th July 2017 Uncategorised 0Eli Lilly beat sales estimates in the second quarter, thanks to successful launches of drugs like Taltz to treat psoriasis. But the pressure is on to continue to innovate, so the company is revising its oncology strategy to boost its chances of further success.
More: Lilly’s catch-up act in psoriasis is working, but now it has to catch up in cancer
Source: fierce